{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:21:24Z","timestamp":1794640884436,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["5I01BX001000-06"],"award-info":[{"award-number":["5I01BX001000-06"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015502","name":"Dialysis Clinics","doi-asserted-by":"publisher","award":["C-4149"],"award-info":[{"award-number":["C-4149"]}],"id":[{"id":"10.13039\/100015502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["TS240031"],"award-info":[{"award-number":["TS240031"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2010736"],"award-info":[{"award-number":["W81XWH2010736"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH1910474"],"award-info":[{"award-number":["W81XWH1910474"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["NHLBIT32HL007736"],"award-info":[{"award-number":["NHLBIT32HL007736"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL138481"],"award-info":[{"award-number":["R01HL138481"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["1R01DK136554-01"],"award-info":[{"award-number":["1R01DK136554-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["4R00DK127215-03"],"award-info":[{"award-number":["4R00DK127215-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The epithelium of kidney cysts in mouse Tuberous Sclerosis complex (TSC) models and TSC patients is composed of proliferating A-intercalated cells. The ablation of the\n                    <jats:italic>Foxi1<\/jats:italic>\n                    gene abolished renal cystogenesis in principal cell-specific\n                    <jats:italic>Tsc1<\/jats:italic>\n                    knockout (\n                    <jats:italic>Tsc1-KO<\/jats:italic>\n                    ) mice. RNAseq studies comparing kidneys of\n                    <jats:italic>Tsc1-KO<\/jats:italic>\n                    vs. wild-type (WT) and\n                    <jats:italic>Tsc1\/Foxi1<\/jats:italic>\n                    -double-knockout identified c\n                    <jats:italic>-Kit<\/jats:italic>\n                    , a tyrosine kinase receptor (RTK), as a transcript whose expression significantly increased in\n                    <jats:italic>Tsc1-KO<\/jats:italic>\n                    mice. Overexpression of FOXI1 in kidney M-1 cells significantly increased\n                    <jats:italic>c-Kit<\/jats:italic>\n                    expression levels. Kidney cystogenesis was abolished in\n                    <jats:italic>Tsc1<\/jats:italic>\n                    -\n                    <jats:italic>KO<\/jats:italic>\n                    mice by inactivating the\n                    <jats:italic>c-Kit<\/jats:italic>\n                    gene via the generation of\n                    <jats:italic>Tsc1\/c-Kit<\/jats:italic>\n                    -double-knockout mice. The treatment of\n                    <jats:italic>Tsc1<\/jats:italic>\n                    -\n                    <jats:italic>KO<\/jats:italic>\n                    mice with Imatinib, a specific inhibitor of c-KIT, significantly diminished kidney cystogenesis. Renal cystogenesis was associated with ERK1\/2, AKT, and RSK1-mediated phospho-inactivation of TSC2. In contrast, activation of ERK1\/2, AKT, and RSK1, as well as phosphorylation of TSC2, was notably reduced in the kidneys of\n                    <jats:italic>Tsc1\/c-Kit-dKO<\/jats:italic>\n                    mice. We propose that c-KIT is a crucial mediator of TSC renal cystogenesis and that its inhibition may constitute a novel approach for the treatment of kidney cysts in TSC.\n                  <\/jats:p>","DOI":"10.1038\/s44321-025-00360-x","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:31:37Z","timestamp":1766395897000},"page":"575-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The critical role of the proto-oncogene c-Kit in TSC renal cystogenesis"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4257-5107","authenticated-orcid":false,"given":"Kamyar","family":"Zahedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5710-292X","authenticated-orcid":false,"given":"Sharon","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6582-2281","authenticated-orcid":false,"given":"Marybeth","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8771-0747","authenticated-orcid":false,"given":"Wenzheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane J","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan A","family":"Zaidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4909-4469","authenticated-orcid":false,"given":"Manoocher","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"360_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1357-2725(99)00076-X","volume":"31","author":"LK Ashman","year":"1999","unstructured":"Ashman LK (1999) The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol 31:1037\u20131051","journal-title":"Int J Biochem Cell Biol"},{"key":"360_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92461-z","volume":"11","author":"S Bansod","year":"2021","unstructured":"Bansod S, Saifi MA, Godugu C (2021) Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model. Sci Rep 11:12894","journal-title":"Sci Rep"},{"key":"360_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11523-011-0202-9","volume":"6","author":"NA Barber","year":"2011","unstructured":"Barber NA, Afzal W, Akhtari M (2011) Hematologic toxicities of small molecule tyrosine kinase inhibitors. Target Oncol 6:203\u2013215","journal-title":"Target Oncol"},{"key":"360_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajpath.2022.10.007","volume":"193","author":"S Barone","year":"2023","unstructured":"Barone S, Brooks M, Zahedi K, Holliday LS, Bissler J, Yu JJ, Soleimani M (2023) Identification of an electrogenic 2Cl(-)\/H(+) exchanger, ClC5, as a chloride-secreting transporter candidate in kidney cyst epithelium in tuberous sclerosis. Am J Pathol 193:191\u2013200","journal-title":"Am J Pathol"},{"key":"360_CR5","doi-asserted-by":"publisher","first-page":"e2020190118","DOI":"10.1073\/pnas.2020190118","volume":"118","author":"S Barone","year":"2021","unstructured":"Barone S, Zahedi K, Brooks M, Henske EP, Yang Y, Zhang E, Bissler JJ, Yu JJ, Soleimani M (2021) Kidney intercalated cells and the transcription factor FOXI1 drive cystogenesis in tuberous sclerosis complex. Proc Natl Acad Sci USA 118:e2020190118","journal-title":"Proc Natl Acad Sci USA"},{"key":"360_CR6","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.3390\/ijms25094772","volume":"25","author":"S Barone","year":"2024","unstructured":"Barone S, Zahedi K, Brooks M, Soleimani M (2024) Carbonic anhydrase 2 deletion delays the growth of kidney cysts whereas Foxi1 deletion completely abrogates cystogenesis in TSC. Int J Mol Sci 25:4772","journal-title":"Int J Mol Sci"},{"key":"360_CR7","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/ndt\/gfy132","volume":"34","author":"JJ Bissler","year":"2019","unstructured":"Bissler JJ, Budde K, Sauter M, Franz DN, Zonnenberg BA, Frost MD, Belousova E, Berkowitz N, Ridolfi A, Christopher Kingswood J (2019a) Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2. Nephrol Dial Transplant 34:1000\u20131008","journal-title":"Nephrol Dial Transplant"},{"key":"360_CR8","doi-asserted-by":"publisher","first-page":"e13983","DOI":"10.14814\/phy2.13983","volume":"7","author":"JJ Bissler","year":"2019","unstructured":"Bissler JJ, Zadjali F, Bridges D, Astrinidis A, Barone S, Yao Y, Redd JR, Siroky BJ, Wang Y, Finley JT et al (2019b) Tuberous sclerosis complex exhibits a new renal cystogenic mechanism. Physiol Rep 7:e13983","journal-title":"Physiol Rep"},{"key":"360_CR9","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1172\/JCI20665","volume":"113","author":"SR Blomqvist","year":"2004","unstructured":"Blomqvist SR, Vidarsson H, Fitzgerald S, Johansson BR, Ollerstam A, Brown R, Persson AE, Bergstrom GG, Enerback S (2004) Distal renal tubular acidosis in mice that lack the forkhead transcription factor Foxi1. J Clin Invest 113:1560\u20131570","journal-title":"J Clin Invest"},{"key":"360_CR10","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.prp.2016.04.005","volume":"212","author":"SM Bonsib","year":"2016","unstructured":"Bonsib SM, Boils C, Gokden N, Grignon D, Gu X, Higgins JP, Leroy X, McKenney JK, Nasr SH, Phillips C et al (2016) Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms. Pathol Res Pract 212:972\u2013979","journal-title":"Pathol Res Pract"},{"key":"360_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.18632\/oncoscience.51","volume":"1","author":"MS Carlino","year":"2014","unstructured":"Carlino MS, Todd JR, Rizos H (2014) Resistance to c-Kit inhibitors in melanoma: insights for future therapies. Oncoscience 1:423\u2013426","journal-title":"Oncoscience"},{"key":"360_CR12","doi-asserted-by":"publisher","first-page":"F572","DOI":"10.1152\/ajprenal.00436.2017","volume":"314","author":"L Chen","year":"2018","unstructured":"Chen L, Gao C, Zhang L, Zhang Y, Chen E, Zhang W (2018) Highly tamoxifen-inducible principal cell-specific Cre mice with complete fidelity in cell specificity and no leakiness. Am J Physiol Renal Physiol 314:F572\u2013F583","journal-title":"Am J Physiol Renal Physiol"},{"key":"360_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0887-2333(97)00107-0","volume":"12","author":"K Chiba","year":"1998","unstructured":"Chiba K, Kawakami K, Tohyama K (1998) Simultaneous evaluation of cell viability by neutral red, MTT and crystal violet staining assays of the same cells. Toxicol In Vitro 12:251\u2013258","journal-title":"Toxicol In Vitro"},{"key":"360_CR14","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex. N Engl J Med 355:1345\u20131356","journal-title":"N Engl J Med"},{"key":"360_CR15","doi-asserted-by":"publisher","first-page":"45952","DOI":"10.1074\/jbc.M104360200","volume":"276","author":"CA Curat","year":"2001","unstructured":"Curat CA, Eck M, Dervillez X, Vogel WF (2001) Mapping of epitopes in discoidin domain receptor 1 critical for collagen binding. J Biol Chem 276:45952\u201345958","journal-title":"J Biol Chem"},{"key":"360_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejphar.2008.10.014","volume":"599","author":"E Day","year":"2008","unstructured":"Day E, Waters B, Spiegel K, Alnadaf T, Manley PW, Buchdunger E, Walker C, Jarai G (2008) Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib. Eur J Pharmacol 599:44\u201353","journal-title":"Eur J Pharmacol"},{"key":"360_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","volume":"47","author":"CC Dibble","year":"2012","unstructured":"Dibble CC, Elis W, Menon S, Qin W, Klekota J, Asara JM, Finan PM, Kwiatkowski DJ, Murphy LO, Manning BD (2012) TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol Cell 47:535\u2013546","journal-title":"Mol Cell"},{"key":"360_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/ncb2763","volume":"15","author":"CC Dibble","year":"2013","unstructured":"Dibble CC, Manning BD (2013) Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat Cell Biol 15:555\u2013564","journal-title":"Nat Cell Biol"},{"key":"360_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0782-4","volume":"17","author":"Z Du","year":"2018","unstructured":"Du Z, Lovly CM (2018) Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer 17:58","journal-title":"Mol Cancer"},{"key":"360_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000074470","volume":"65","author":"F Duffaud","year":"2003","unstructured":"Duffaud F, Blay JY (2003) Gastrointestinal stromal tumors: biology and treatment. Oncology 65:187\u2013197","journal-title":"Oncology"},{"key":"360_CR21","doi-asserted-by":"publisher","first-page":"pdb-prot087379","DOI":"10.1101\/pdb.prot087379","volume":"2016","author":"M Feoktistova","year":"2016","unstructured":"Feoktistova M, Geserick P, Leverkus M (2016) Crystal violet assay for determining viability of cultured cells. Cold Spring Harb Protoc 2016:pdb-prot087379","journal-title":"Cold Spring Harb Protoc"},{"key":"360_CR22","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1038\/sj.onc.1207542","volume":"23","author":"DC Fingar","year":"2004","unstructured":"Fingar DC, Blenis J (2004) Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23:3151\u20133171","journal-title":"Oncogene"},{"key":"360_CR23","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","volume":"11","author":"A Garami","year":"2003","unstructured":"Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H, Kozma SC, Hafen E, Bos JL, Thomas G (2003) Insulin activation of Rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11:1457\u20131466","journal-title":"Mol Cell"},{"key":"360_CR24","doi-asserted-by":"publisher","first-page":"e1006242","DOI":"10.1371\/journal.pgen.1006242","volume":"12","author":"K Giannikou","year":"2016","unstructured":"Giannikou K, Malinowska IA, Pugh TJ, Yan R, Tseng YY, Oh C, Kim J, Tyburczy ME, Chekaluk Y, Liu Y et al (2016) Whole exome sequencing identifies TSC1\/TSC2 biallelic loss as the primary and sufficient driver event for renal angiomyolipoma development. PLoS Genet 12:e1006242","journal-title":"PLoS Genet"},{"key":"360_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.35","volume":"2","author":"EP Henske","year":"2016","unstructured":"Henske EP, Jozwiak S, Kingswood JC, Sampson JR, Thiele EA (2016) Tuberous sclerosis complex. Nat Rev Dis Primers 2:16035","journal-title":"Nat Rev Dis Primers"},{"key":"360_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/gcc.2870130411","volume":"13","author":"EP Henske","year":"1995","unstructured":"Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MP, Kwiatkowski DJ (1995) Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer 13:295\u2013298","journal-title":"Genes Chromosomes Cancer"},{"key":"360_CR27","first-page":"400","volume":"59","author":"EP Henske","year":"1996","unstructured":"Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N, van Slegtenhorst M, Welsh CT, Kwiatkowski DJ (1996) Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 59:400\u2013406","journal-title":"Am J Hum Genet"},{"key":"360_CR28","first-page":"1639","volume":"151","author":"EP Henske","year":"1997","unstructured":"Henske EP, Wessner LL, Golden J, Scheithauer BW, Vortmeyer AO, Zhuang Z, Klein-Szanto AJ, Kwiatkowski DJ, Yeung RS (1997) Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol 151:1639\u20131647","journal-title":"Am J Pathol"},{"key":"360_CR29","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1172\/JCI10720","volume":"107","author":"G Hou","year":"2001","unstructured":"Hou G, Vogel W, Bendeck MP (2001) The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair. J Clin Invest 107:727\u2013735","journal-title":"J Clin Invest"},{"key":"360_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang J, Manning BD (2008) The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 412:179\u2013190","journal-title":"Biochem J"},{"key":"360_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1182\/blood-2007-10-118232","volume":"112","author":"Y Huang","year":"2008","unstructured":"Huang Y, Comiskey EO, Dupree RS, Li S, Koleske AJ, Burkhardt JK (2008) The c-Abl tyrosine kinase regulates actin remodeling at the immune synapse. Blood 112:111\u2013119","journal-title":"Blood"},{"key":"360_CR32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.humpath.2005.01.011","volume":"36","author":"L Huo","year":"2005","unstructured":"Huo L, Sugimura J, Tretiakova MS, Patton KT, Gupta R, Popov B, Laskin WB, Yeldandi A, Teh BT, Yang XJ (2005) C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum Pathol 36:262\u2013268","journal-title":"Hum Pathol"},{"key":"360_CR33","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki K, Li Y, Xu T, Guan KL (2003) Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17:1829\u20131834","journal-title":"Genes Dev"},{"key":"360_CR34","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1158\/1078-0432.CCR-13-3033","volume":"20","author":"TS Kim","year":"2014","unstructured":"Kim TS, Cavnar MJ, Cohen NA, Sorenson EC, Greer JB, Seifert AM, Crawley MH, Green BL, Popow R, Pillarsetty N et al (2014) Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor. Clin Cancer Res 20:2350\u20132362","journal-title":"Clin Cancer Res"},{"key":"360_CR35","doi-asserted-by":"publisher","first-page":"F267","DOI":"10.1152\/ajprenal.00272.2022","volume":"324","author":"M Kui","year":"2023","unstructured":"Kui M, Pluznick JL, Zaidman NA (2023) The transcription factor Foxi1 promotes expression of V-ATPase and Gpr116 in M-1 cells. Am J Physiol Renal Physiol 324:F267\u2013F273","journal-title":"Am J Physiol Renal Physiol"},{"key":"360_CR36","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41581-018-0059-6","volume":"14","author":"HC Lam","year":"2018","unstructured":"Lam HC, Siroky BJ, Henske EP (2018) Renal disease in tuberous sclerosis complex: pathogenesis and therapy. Nat Rev Nephrol 14:704\u2013716","journal-title":"Nat Rev Nephrol"},{"key":"360_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","volume":"121","author":"L Ma","year":"2005","unstructured":"Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP (2005) Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121:179\u2013193","journal-title":"Cell"},{"key":"360_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","volume":"10","author":"BD Manning","year":"2002","unstructured":"Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway. Mol Cell 10:151\u2013162","journal-title":"Mol Cell"},{"key":"360_CR39","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb2329","volume":"13","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova MM, Shaw RJ (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13:1016\u20131023","journal-title":"Nat Cell Biol"},{"key":"360_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/jcp.2003.013532","volume":"57","author":"D Miliaras","year":"2004","unstructured":"Miliaras D, Karasavvidou F, Papanikolaou A, Sioutopoulou D (2004) KIT expression in fetal, normal adult, and neoplastic renal tissues. J Clin Pathol 57:463\u2013466","journal-title":"J Clin Pathol"},{"key":"360_CR41","doi-asserted-by":"publisher","first-page":"1518S","DOI":"10.1093\/jn\/137.6.1518S","volume":"137","author":"B Nagar","year":"2007","unstructured":"Nagar B (2007) c-Abl tyrosine kinase and inhibition by the cancer drug imatinib (Gleevec\/STI-571). J Nutr 137:1518S\u20131523S","journal-title":"J Nutr"},{"key":"360_CR42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1365-2141.1995.tb05364.x","volume":"91","author":"Y Nakata","year":"1995","unstructured":"Nakata Y, Kimura A, Katoh O, Kawaishi K, Hyodo H, Abe K, Kuramoto A, Satow Y (1995) c-kit point mutation of extracellular domain in patients with myeloproliferative disorders. Br J Haematol 91:661\u2013663","journal-title":"Br J Haematol"},{"key":"360_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1086\/321972","volume":"69","author":"Y Niida","year":"2001","unstructured":"Niida Y, Stemmer-Rachamimov AO, Logrip M, Tapon D, Perez R, Kwiatkowski DJ, Sims K, MacCollin M, Louis DN, Ramesh V (2001) Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet 69:493\u2013503","journal-title":"Am J Hum Genet"},{"key":"360_CR44","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI7319","volume":"104","author":"H Onda","year":"1999","unstructured":"Onda H, Lueck A, Marks PW, Warren HB, Kwiatkowski DJ (1999) Tsc2(+\/\u2212) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest 104:687\u2013695","journal-title":"J Clin Invest"},{"key":"360_CR45","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1750-3639.2010.00416.x","volume":"20","author":"W Qin","year":"2010","unstructured":"Qin W, Chan JA, Vinters HV, Mathern GW, Franz DN, Taillon BE, Bouffard P, Kwiatkowski DJ (2010) Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events. Brain Pathol 20:1096\u20131105","journal-title":"Brain Pathol"},{"key":"360_CR46","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","volume":"70","author":"SK Rakowski","year":"2006","unstructured":"Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA (2006) Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. Kidney Int 70:1777\u20131782","journal-title":"Kidney Int"},{"key":"360_CR47","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3390\/cancers7030860","volume":"7","author":"T Regad","year":"2015","unstructured":"Regad T (2015) Targeting RTK signaling pathways in cancer. Cancers 7:1758\u20131784","journal-title":"Cancers"},{"key":"360_CR48","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1038\/sj.onc.1203957","volume":"19","author":"DR Robinson","year":"2000","unstructured":"Robinson DR, Wu YM, Lin SF (2000) The protein tyrosine kinase family of the human genome. Oncogene 19:5548\u20135557","journal-title":"Oncogene"},{"key":"360_CR49","doi-asserted-by":"publisher","first-page":"13489","DOI":"10.1073\/pnas.0405659101","volume":"101","author":"PP Roux","year":"2004","unstructured":"Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J (2004) Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci USA 101:13489\u201313494","journal-title":"Proc Natl Acad Sci USA"},{"key":"360_CR50","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.str.2007.01.015","volume":"15","author":"MA Seeliger","year":"2007","unstructured":"Seeliger MA, Nagar B, Frank F, Cao X, Henderson MN, Kuriyan J (2007) c-Src binds to the cancer drug imatinib with an inactive Abl\/c-Kit conformation and a distributed thermodynamic penalty. Structure 15:299\u2013311","journal-title":"Structure"},{"key":"360_CR51","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-3-540-46091-6_12","volume":"176","author":"J Siehl","year":"2007","unstructured":"Siehl J, Thiel E (2007) C-kit, GIST, and imatinib. Recent Results Cancer Res 176:145\u2013151","journal-title":"Recent Results Cancer Res"},{"key":"360_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1289388","volume":"14","author":"M Soleimani","year":"2023","unstructured":"Soleimani M (2023) Not all kidney cysts are created equal: a distinct renal cystogenic mechanism in tuberous sclerosis complex (TSC). Front Physiol 14:1289388","journal-title":"Front Physiol"},{"key":"360_CR53","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1158\/1078-0432.CCR-07-4102","volume":"14","author":"S Tabone-Eglinger","year":"2008","unstructured":"Tabone-Eglinger S, Subra F, El Sayadi H, Alberti L, Tabone E, Michot JP, Theou-Anton N, Lemoine A, Blay JY, Emile JF (2008) KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors. Clin Cancer Res 14:2285\u20132294","journal-title":"Clin Cancer Res"},{"key":"360_CR54","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","volume":"13","author":"AR Tee","year":"2003","unstructured":"Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J (2003) Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 13:1259\u20131268","journal-title":"Curr Biol"},{"key":"360_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep30832","volume":"6","author":"Y Tsutsui","year":"2016","unstructured":"Tsutsui Y, Deredge D, Wintrode PL, Hays FA (2016) Imatinib binding to human c-Src is coupled to inter-domain allostery and suggests a novel kinase inhibition strategy. Sci Rep 6:30832","journal-title":"Sci Rep"},{"key":"360_CR56","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1182\/blood.V80.2.374.374","volume":"80","author":"AM Turner","year":"1992","unstructured":"Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC (1992) Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 80:374\u2013381","journal-title":"Blood"},{"key":"360_CR57","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ana.10283","volume":"52","author":"EJ Uhlmann","year":"2002","unstructured":"Uhlmann EJ, Wong M, Baldwin RL, Bajenaru ML, Onda H, Kwiatkowski DJ, Yamada K, Gutmann DH (2002) Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol 52:285\u2013296","journal-title":"Ann Neurol"},{"key":"360_CR58","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1158\/1535-7163.MCT-22-0224","volume":"22","author":"U Unachukwu","year":"2023","unstructured":"Unachukwu U, Sonett J, Woode D, Shiomi T, Chada K, D\u2019Armiento JM (2023) Tyrosine kinase inhibitors diminish renal neoplasms in a tuberous sclerosis model via induction of apoptosis. Mol Cancer Ther 22:844\u2013858","journal-title":"Mol Cancer Ther"},{"key":"360_CR59","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1128\/MCB.21.8.2906-2917.2001","volume":"21","author":"WF Vogel","year":"2001","unstructured":"Vogel WF, Aszodi A, Alves F, Pawson T (2001) Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol 21:2906\u20132917","journal-title":"Mol Cell Biol"},{"key":"360_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1182\/blood-2003-07-2554","volume":"104","author":"E Wandzioch","year":"2004","unstructured":"Wandzioch E, Edling CE, Palmer RH, Carlsson L, Hallberg B (2004) Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor\/stem cell lines. Blood 104:51\u201357","journal-title":"Blood"},{"key":"360_CR61","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41392-023-01327-5","volume":"8","author":"L Wang","year":"2023","unstructured":"Wang L, Gu S, Chen F, Yu Y, Cao J, Li X, Gao C, Chen Y, Yuan S, Liu X et al (2023) Imatinib blocks tyrosine phosphorylation of Smad4 and restores TGF-beta growth-suppressive signaling in BCR-ABL1-positive leukemia. Signal Transduct Target Ther 8:120","journal-title":"Signal Transduct Target Ther"},{"key":"360_CR62","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3727\/096504018X15331163433914","volume":"27","author":"X Wei","year":"2019","unstructured":"Wei X, Mao L, Chi Z, Sheng X, Cui C, Kong Y, Dai J, Wang X, Li S, Tang B et al (2019) Efficacy evaluation of imatinib for the treatment of melanoma: evidence from a retrospective study. Oncol Res 27:495\u2013501","journal-title":"Oncol Res"},{"key":"360_CR63","doi-asserted-by":"publisher","first-page":"7934","DOI":"10.1158\/0008-5472.CAN-06-1740","volume":"66","author":"C Wilson","year":"2006","unstructured":"Wilson C, Bonnet C, Guy C, Idziaszczyk S, Colley J, Humphreys V, Maynard J, Sampson JR, Cheadle JP (2006) Tsc1 haploinsufficiency without mammalian target of rapamycin activation is sufficient for renal cyst formation in Tsc1+\/\u2212 mice. Cancer Res 66:7934\u20137938","journal-title":"Cancer Res"},{"key":"360_CR64","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.15252\/embj.201796700","volume":"36","author":"MR Woodford","year":"2017","unstructured":"Woodford MR, Sager RA, Marris E, Dunn DM, Blanden AR, Murphy RL, Rensing N, Shapiro O, Panaretou B, Prodromou C et al (2017) Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clients. EMBO J 36:3650\u20133665","journal-title":"EMBO J"},{"key":"360_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-46","volume":"5","author":"A Yasuda","year":"2006","unstructured":"Yasuda A, Sawai H, Takahashi H, Ochi N, Matsuo Y, Funahashi H, Sato M, Okada Y, Takeyama H, Manabe T (2006) The stem cell factor\/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells. Mol Cancer 5:46","journal-title":"Mol Cancer"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00360-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00360-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00360-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:44:15Z","timestamp":1779065055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00360-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":65,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,13]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00360-x","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}